Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSS2300004	雷珠单抗注射液	ranibizumab	Injection	Biological Products(3.3)	New Drug Application	2023-01-29		QILU Pharmaceutical Co Ltd			view
JYSB2500035	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Supplementary Application	2025-02-13		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
CXSL2101029	重组抗VEGF人源化单克隆抗体Fab片段注射液	ranibizumab	Injection	Biological Products(3.3)	New Drug Application	2021-04-21		Jecho Biopharmaceuticals Co Ltd			view
JXSL2200083	雷珠单抗注射液	ranibizumab	Injection	Biological Products(3.3)	Import Drug Application	2022-06-13		Samsung Bioepis NL BV			view
JYSB2300087	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Supplementary Application	2023-05-09		Novartis Pharma Schweiz AG			view
JYSZ2200031	雷珠单抗注射液	ranibizumab	Injection	Biological Products	License Renew	2022-07-06		Vetter Pharma-Fertigung Gmbh & Co KG;Novartis Pharma Schweiz AG			view
JYSB2300066	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Supplementary Application	2023-04-14		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
JYSB2200118	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Supplementary Application	2022-07-07		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
JYSB2300065	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Supplementary Application	2023-04-14		Vetter Pharma-Fertigung Gmbh & Co KG;Novartis Pharma Schweiz AG			view
JYSZ2100514	雷珠单抗注射液	ranibizumab	Injection	Biological Products	License Renew	2021-05-10		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
JYSB2300015	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Supplementary Application	2023-02-03		Novartis Pharma Stein AG;Novartis Pharma Schweiz AG			view
JXSL2101039	雷珠单抗注射液	ranibizumab	Injection	Biological Products(2.1)	Import Drug Application	2021-06-07		F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd			view
JXSL0600043	雷珠单抗注射液	ranibizumab	Injection	Biological Products(7)	Import Drug Application	2006-11-23	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2008-06-20	view
JXSL0800023	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Import Drug Application	2008-09-09	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2009-04-21	view
JXSL1000035	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Import Drug Application	2010-08-16	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Europharm Ltd	Certificate Issued	2011-02-18	view
JXSL1000041	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Import Drug Application	2010-09-09	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Europharm Ltd	Certificate Issued	2011-08-02	view
JXSS1000001	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Import Drug Application	2010-04-08	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG	Certificate Issued	2012-01-11	view
JXSL1100020	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Import Drug Application	2011-04-01	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Europharm Ltd	Certificate Issued	2012-07-04	view
JXSL1200049	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Import Drug Application	2012-07-06	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2013-08-26	view
JYSB1400006	雷珠单抗注射液	ranibizumab	Injection	Biological Products	Supplementary Application	2014-05-30	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG	Certificate Issued	2014-11-25	view